Franck Letournel

Franck Letournel

Auto-generated profile, based on publicly available information

Franck Letournel

Univ Angers, CHU Angers, Inserm, CNRS, MINT, SFR ICAT, Angers F-49000, France; Laboratoire de Neurobiologie et Neuropathologie, Centre Hospitalier Universitaire d'Angers, Angers, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2013 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SLSuzanne Lesage
Suzanne Lesage
MAMathieu Anheim
Mathieu Anheim
FLFranck Letournel
Franck Letournel
LBLuc Bousset
Luc Bousset
AHAurélie Honoré
Aurélie Honoré
FGfor the French Parkinson's Disease Genetics Study Group
for the French Parkinson's Disease Genetics Study Group

24 December 2007 in Brain
Verified
Journal Article
Open access
PDF file
PAPatrizia Amati-Bonneau
Patrizia Amati-Bonneau
MVMaria Lucia Valentino
Maria Lucia Valentino
PRPascal Reynier
Pascal Reynier
M. ESTHER GALLARDO PEREZM. ESTHER GALLARDO PEREZ
M. ESTHER GALLARDO PEREZ
BBBelén Bornstein
Belén Bornstein
Valerio CarelliValerio Carelli
Valerio Carelli
Mutations in OPA1, a dynamin-related GTPase involved in mitochondrial fusion, cristae organization and control of apoptosis, have been linked to non-syndromic optic neuropathy transmitted as an autosomal-dominant trait (DOA). We here report on eight patients from six independent families showing that mutations in the OPA1 gene can also be responsible for a syndromic form of DOA associated with sensorineural deafness, ataxia, axonal sensory-motor polyneuropathy, chronic progressive external ophthalmoplegia and mitochondrial myopathy with cytochrome c oxidase negative and Ragged Red Fibres. Most remarkably, we demonstrate that these patients all harboured multiple deletions of mitochondrial DNA (mtDNA) in their skeletal muscle, thus revealing an unrecognized role of the OPA1 protein in mtDNA stability. The five OPA1 mutations associated with these DOA ‘plus’ phenotypes were all mis-sense point mutations affecting highly conserved amino acid positions and the nuclear genes previously known to induce mtDNA multiple deletions such as POLG1, PEO1 (Twinkle) and SLC25A4 (ANT1) were ruled out. Our results show that certain OPA1 mutations exert a dominant negative effect responsible for multi-systemic disease, closely related to classical mitochondrial cytopathies, by a mechanism involving mtDNA instability.

7 September 2006 in Brain
Verified
Journal Article
Open access
PDF file
LCLucie Cabrejo
Lucie Cabrejo
LGLucie Guyant-Maréchal
Lucie Guyant-Maréchal
ALAnnie Laquerrière
Annie Laquerrière
MVMartine Vercelletto
Martine Vercelletto
FFFrançois De La Fournière
François De La Fournière
DHDidier Hannequin
Didier Hannequin
Different duplications of the APP locus have been identified in five families with autosomal dominant early onset Alzheimer's disease (ADEOAD) and Aβ-related cerebral amyloid angiopathy (CAA). This study describes the phenotype of this new entity. Clinical, neuropsychological, imagery and neuropathological data were reviewed. The phenotype was not dependent on the size of the duplication and there was no clinical feature of Down's syndrome. Dementia was observed in all cases; intracerebral haemorrhage (ICH) was reported in 6 (26%) and seizures occurred in 12 (57%) of 21 patients. Age of onset of dementia ranged from 42 to 59 years, ICH from 53 to 64 years and age at death from 46 to 75 years. The neuropathological findings in five cases demonstrated Alzheimer's disease and severe CAA lesions that were reminiscent from those reported in brains of Down's syndrome patients. A striking feature consisted in intraneuronal Aβx-40 accumulation located in the granular cell layer of the dentate gyrus and in the pyramidal cell layer of the Ammon's horn.

1 June 2014 in Cell
Verified
Journal Article
Closed access
EMEstelle Marion
Estelle Marion
OSOk-Ryul Song
Ok-Ryul Song
TCThierry Christophe
Thierry Christophe
JBJérémie Babonneau
Jérémie Babonneau
DFDenis Fenistein
Denis Fenistein
PBPriscille Brodin
Priscille Brodin

4 August 2016 in Journal of Parkinson’s Disease
Verified
Journal Article
Closed access
PDF file
TBThomas G. Beach
Thomas G. Beach
ACAnne-Gaëlle Corbillé
Anne-Gaëlle Corbillé
FLFranck Letournel
Franck Letournel
JKJeffrey H. Kordower
Jeffrey H. Kordower
TKThomas Kremer
Thomas Kremer
PDPascal Derkinderen
Pascal Derkinderen
Background: Conflicting results from studies of Lewy-type α−synucleinopathy (LTS) in colonic biopsies of subjects with Parkinson’s disease (PD) prompted a two-part multicenter assessment. The first assessment, now published (Acta Neuropathol Commun 4 : 35, 2016), examined archived colonic biopsies and found that none of the tested methods was adequately sensitive or specific. Objective: As the amount of nervous tissue in typical colonic biopsies may be insufficient, and the clinical diagnosis of PD not completely accurate, the objective of the current study was to use instead full-thickness sections of sigmoid colon from autopsy-proven PD and normal subjects. Methods: Seven different immunohistochemical (IHC) methods were used, employing five different primary antibodies and four different combinations of epitope exposure and signal development protocols. Specific staining was defined as being restricted to morphological features consistent with neuronal elements. Stained slides from each subject were independently categorized as being positive or negative for LTS, and their density semi-quantitatively graded, by four raters blinded to diagnosis. Results: Agreement and mean diagnostic performance varied markedly between raters. With the two most accurate raters, 5 methods achieved diagnostic accuracies of 70% or greater; one method had 100% accuracy and 100% inter-rater agreement. The submucosa had the highest prevalence of pathological LTS staining, followed by the muscularis and mucosa. Conclusions: The major conclusion of this study is that, when sufficient submucosa and LTS is present, and when specific staining is defined as being consistent with neuronal morphology, adequately-trained raters may reliably distinguish PD colon from control using suitable IHC methods.

17 December 2008 in neurogenetics
Verified
Journal Article
Closed access
PDF file
JCJulien Cassereau
Julien Cassereau
ACArnaud CHEVROLLIER
Arnaud CHEVROLLIER
NGNaïg Gueguen
Naïg Gueguen
MMMarie-Claire Malinge
Marie-Claire Malinge
FLFranck Letournel
Franck Letournel
PRPascal Reynier
Pascal Reynier